Research carried out by scientists at a Scottish university has shown the diabetes drug metformin may have the potential of being developed into a new treatment for patients with heart failure,
Metformin is the world’s most commonly prescribed diabetes medicine, and researchers from Dundee University have previously established that metformin affords type-2 diabetes patients protection against both cancer and cardiovascular disease.
But a new study, led by Chim Lang, professor of cardiology, has shown that metformin may prove beneficial to patients suffering from heart failure. The results of the latest study have been published in the European Journal of Heart Failure.